Clinical trial registry record

Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer: Prospective Cohort Study in Brazil

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 26, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07773285
Last registry update
August 26, 2026
Status
Not Yet Recruiting
Phase
Phase not reported
Sponsor
Latin American Cooperative Oncology Group
Enrollment
250
Countries
Brazil
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
250
Population
ALL · 70 Years
Duration
2026-09-01 to 2030-09-01
Intervention
Comparator
Not reported
Outcomes measured
Sensitivity of the G8 screening tool for frailty — Baseline; Early Mortality — 6 months; Overall Survival at 12 and 36 months — 12 months and 36 months.; Operational Characteristics of the G8 Tool for Frailty — Baseline; Overall Survival Stratified by G8 Classification — 6 months and 36 months; Predictive ability of the G8 score — 6 and 36 months; discrimination and calibration of a risk model — up to 36 months; Prevalence of Frailty Indicators — Baseline; Sociodemographic and Clinical Factors Associated With Frailty and Early Mortality — Up to 6 months; Regional disparities in G8 performance — Up to 36 months; Comparative analysis of G8 versus CGA — Up to 36 months; Hospitalization rates within 6 months according to G8. — Up to 6 months; Operational Characteristics of G8 for Survival — 6 months and 36 months.
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled term: cancer. Abstract contains controlled term: tumor. Source terminology contains: tumor. Title supplies longevity context: frailty, frail. Study type is explicitly identified as OBSERVATIONAL.
  • Frailty · 80%Title contains controlled term: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.